RecruitingNCT05548621
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
Sponsor
St. Antonius Hospital
Enrollment
180 participants
Start Date
Nov 24, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of this study is to evaluate the effect of two decision aids for renal cell carcinoma (RCC) on the decision-making process and the quality of the decision.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Patients clinically diagnosed with RCC
- Patients facing a decision which is addressed in the decision aids (T1 tumor or metastatic disease)
- Written informed consent
Exclusion Criteria1
- Patients who are not able to fill in a questionnaire or undergo an interview individually
Interventions
OTHERDecision aid
Online interactive decision aid for RCC
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05548621
Related Trials
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
NCT0498150913 locations
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
NCT0711504311 locations
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
NCT057386948 locations
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
NCT000012381 location
Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy
NCT057254211 location